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INTRODUCTION
Keloids are characterized by an excessive accumulation of ex-
tracellular matrix, especially collagen, in an abnormal wound-
healing process.1 Keloids cause cosmetic disfigurement, be-
cause they expand beyond the wound boundary and grow co-
ntinuously, causing subjective symptoms such as itching and 
tingling sensations which disturb the patient’s quality of life. 
The exact mechanism of keloid formation is not known; previ-
ous studies have, however, demonstrated the excessive depo-
sition of collagen in the dermis.2 There are currently no consis-
tently effective treatments, although several different appro-
aches have been reported: intralesional injection of steroids, 
5-fluorouracil (FU), or bleomycin; pressure garments; cryosur-
gery; laser therapy; and radiotherapy.3
Recently, Chen, et al.4,5 reported that heat shock protein 47 
(Hsp47) is overexpressed in keloid fibroblasts, and that the 
overexpression of Hsp47 could induce excessive collagen accu-
mulation by enhancing the synthesis and secretion of collagen.6 
We previously confirmed that Hsp70 is overexpressed in keloid 
fibroblasts relative to normal fibroblasts.7 Also, other studies 
have reported that Hsp70 is overexperessed in keloid tissues.8,9 
However, the functional role of Hsp70 in keloids has not been 
investigated yet. The Hsp70-family proteins act as chaperone 
molecules and protect cells from environmental stressors. They 
are stress-response proteins that are expressed under variety 
of stimuli, binding polypeptides to facilitate the correct fold-
ing, transport, and localization of the mature proteins.10 They 
also associate with denatured or partially unfolded proteins, 
helping the distressed proteins to refold. Thus, we hypothesize 
that Hsp70 plays a protective role in keloid fibroblasts, helping 
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the cells to sustain a highly active metabolic state, allowing 
the cells to produce excessive collagen fibers and other extra-
cellular matrix proteins, thus promoting pathogenic keloid 
development. 
MATERIALS AND METHODS
Patients and sample collections 
We obtained and cultured keloid-fibroblast samples from five 
patients in Severance Hospital, Yonsei University College of 
Medicine, Seoul, Korea as described previously.11 All patients 
provided informed written consent for the use of their tissues 
for research purposes, and the Institutional Review Board of 
Yonsei University Medical Center approved the tissue-harvest-
ing procedure. None of patients had undergone previous ke-
loid treatment. 
Primary fibroblast cell culture
Primary fibroblasts were cultured in Dulbecco’s modified Ea-
gle’s medium (DMEM; GIBCO, Grand Island, NY, USA) sup-
plemented with heat-inactivated 10% fetal bovine serum (FBS), 
penicillin, and streptomycin. We used only cells before passage 
5 in the experiments described here. 
Immunohistochemical assessment in tissues
Immunohistochemistry (IHC) was performed in 10% forma-
lin-fixed, paraffin-embedded keloid tissues. Tissues were pre-
treated with 3% hydrogen peroxide solution for 10 min, washed 
again with distilled water (DW) several times for 10 min each 
and incubated with 1xTBST for 5 min. Tissues were then treat-
ed with normal goat serum (Vector Laboratories, Burlingame, 
CA, USA) at room temperature (RT) for 1 h to prevent non-
specific reactions and incubated overnight with mouse anti-
Hsp70 (ab6535; Abcam, Cambridge, UK) antibody and anti-
transforming growth factor-beta (TGF-ß) (GTX110630; Gene 
Tex, San Antonio, TX, USA) diluted to 1:100. The tissues were 
then washed with 1xTBST and incubated for 30 min at RT with 
biotinylated secondary antibody solution from the Dako RE-
ALTMEnVisionTMDetection System (Dako, Copenhagen, Den-
mark), washed with DW, counter stained with hematoxylin 
(Sigma-Aldrigh, St. Louis, MO, USA), dehydrated and clarified 
by a conventional method, and prepared for examination un-
der a light microscope. 
Construction of siRNAs and transient transfection
We designed two Hsp70 siRNAs targeting the human Hsp70-
1A sequence (Table 1) and synthesized them as double-strand-
ed oligonucleotides (Bioneer, Daejeon, Korea). We seeded fi-
broblasts isolated from the tissue samples in 6-well plates at 
70–80% confluency per well and cultured them for 24 h. We 
diluted the siRNAs in Opti-MEM (Gibco-BRL/Invitrogen, 
Carlsbad, CA, USA) to a 15 nM final concentration and then 
added 30 μL of Lipofectamine RNAiMAX (Invitrogen, Carls-
bad, CA, USA) and incubated the mixture for 20 min at RT. 
The siRNA mixture was then added to the cells and the cells 
were incubated for 5 h in the incubator. At the end of the incu-
bation period, the cell media were changed.
Quantitative real-time PCR
We extracted total RNA with an RNeasy plus mini kit (Qiagen, 
Valencia, CA, USA) according to the manufacturer’s instruc-
tions. We synthesized cDNA using a Transcriptor first strand 
cDNA synthesis kit (Roche, Gipf-Oberfrick, Switzerland) and 
1 μg of total RNA. We conducted real-time polymerase chain 
reaction (PCR) in triplicate using TaqMan master mix (Applied 
Biosystems, Foster City, CA, USA) and the Applied Biosystems 
7500 Real-Time PCR System. We normalized the mRNA ex-
pression levels of Hsp70 (assay ID Hs00359163_s1), tissue in-
hibitor of metalloproteinase (TIMP)-1 (assay ID Hs00171558_
m1), TIMP-2 (assay ID Hs00234278_m1), matrix metalloprot-
einase (MMP)-14 (assay ID Hs00 237119_m1), MMP-2 (assay 
ID Hs01548727_m1), collagen-I (assay ID Hs 00164004_m1) 
and collagen-III (assay ID Hs 00164103_m1) to that of the 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (assay 
ID Hs99999905_m1) housekeeping gene. We performed rela-
tive quantification using the 7500 software v2.0.1 (Applied 
Biosystems).
Western blots
We collected keloid fibroblasts 24 h and 48 h after transfection 
to determine the total levels of Hsp70, MMP-2, MMP-14, TIMP-
1, and TIMP-2. We separated proteins by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE), trans-
ferred them to a nitrocellulose membrane, which was blocked 
1 h with 5% skim milk in 1xTBST, and then incubated them 
overnight at 4°C with monoclonal mouse anti-human Hsp70 
antibody (1:1000, Abcam), MMP-2 antibody (1:1000, Abcam), 
MMP-14 antibody (1:1000, Abcam), TIMP-1 antibody (1:1000, 
Abcam), and TIMP-2 antibody (1:1000, Abcam). The primary 
antibody was detected with horseradish peroxidase-conjugat-
Table 1. The siRNA Sequences Designed in This Study
Sense Anti-sense
siRNA Hsp70-1 5’-CACUACCUUUUUCGAGAGU-3’ 5’-ACUCUCGAAAAAGGUAGUG-3’
siRNA Hsp70-2 5’-GAGCUUCAAGACUUUGCAU-3’ 5’-AUGCAAAGUCUUGAAGCUC-3’
siRNA scrambled 5’-CCUACGCCACCAAUUUCGU-3’ 5’-ACGAAAUUGGUGGCGUAGG-3’
siRNA, small interfering RNA; Hsp70, heat shock protein 70.
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ed secondary antibody goat anti-mouse or rabbit (1:5000, Cell 
signaling, Beverly, MA, USA) and chemiluminescent luminal 
(Las 4000 mini; Fuji, Tokyo, Japan). Immunocomplexes were 
detected using an enhanced horseradish peroxidase/luminol 
chemiluminescence system (ECL Plus; Amersham Interna-
tional plc, Little Chalfont, UK), followed by autoradiography 
(Hyperfilm EC; Amersham International plc). Finally, immu-
noblot signals were quantified using a computer-imaging 
program (GelScopeTM, Imageline Inc., Gardena, CA, USA).
Collagen assay
The total collagen content of 100 μL of media from each cell 
culture after siRNA transfection was determined using the Sir-
col Collagen Assay Kit (Biocolor, Belfast, Northern Ireland) 
according to the manufacturer’s instructions. Briefly, we added 
1 mL of Sircol dye reagent to bind the collagen in each sample 
and then mixed the solutions for 30 min, and then centrifuged 
the solutions at 12000 rpm for 10 min, resuspended the pellets 
in 1 mL of alkali reagent and read the absorbance at 550 nm 
with a spectrophotometer. A standard collagen solution was 
used to construct a standard curve. 
Cell viability assay
A tetrazolium-based colorimetric assay (MTT) assay was used 
to measure cell viability after different treatments. We added 
20 μL of MTT solution (5 mg/mL, Sigma-Aldrich) to each well 
at each designated time point and then incubated the wells 
for 4 h. Then, 250 μL of dimethyl sulphoxide (DMSO) were 
added to dissolve the purple crystalline products of the MTT 
substrates, incubated the mixtures for 30 min, and measured 
absorbance at 570 nm using a plate reader. 
Statistical analysis
We summarized all the data as means±standard deviations 
(SD) and compared the means using paired t-tests and one-
way ANOVAs with p<0.05 as the threshold of statistical signifi-
cance. SPSS version 19.0 (SPSS Inc., Chicago, IL, USA) was used 
for all statistical analyses. 
RESULTS
Hsp70 and TGF-ß expression was significantly 
increased in keloid tissues 
Dense collagen fibers were noted in keloid tissue. Immuno-
histochemical staining of keloids and adjacent normal dermal 
tissue revealed that the expressions of TGF-ß and Hsp70 were 
markedly increased along with dense collagen fibers in keloid 
tissue. Increased expression of TGF-ß and Hsp70 was also not-
ed under adjacent normal dermal tissue (Fig. 1). 
siRNA transfection and Hsp70 suppression did not 
affect keloid fibroblast viability 
There was no statistically significant difference in keloid fibro-
blasts viability after Hsp70 siRNA transfection (Fig. 2A). Neither 
the scrambled siRNA nor the Hsp70 siRNAs influenced the via-
bility of the keloid fibroblasts, indicating that the suppression of 
Hsp70 had no influence on keloid fibroblast viability. 
siRNAs suppressed Hsp70 levels 
The quantitative real-time PCR and western blot results showed 
that siRNAs effectively suppressed both Hsp70 mRNA and 
protein levels (p<0.05) (Fig. 2B and C). Hsp70 siRNA-1 sup-
pressed Hsp70 mRNA levels more consistently than Hsp70 
siRNA-2. Therefore, we selected Hsp70 siRNA-1 for further in-
vestigation. 
Hsp70 siRNA transfection suppressed collagen 
production
Fig. 3 shows that both intracellular collagen production and ex-
tracellular collagen secretion were markedly suppressed after 
24 h and 48 h of transfection. Relative to those in the control 
Fig. 1. Immunohistochemical staining of keloids and adjacent normal 
dermal tissues. Abnormal dense collagen fibers were extending over 
clinical keloid margin (dotted line). The expression of Hsp70 and TGF-ß1 
were also increased along with extending collagen fibers (x100, scale 
bar: 1 mm). Each experiment was performed in triplicate; representative 
data are shown here. Hsp70, heat shock protein 70; TGF-ß1, transform-
ing growth factor-beta1.
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Fig. 2. The expression of Hsp70 was down-regulated by Hsp70 siRNA transfection. (A) MTT viability of keloid fibroblasts after siRNA transfection. Re-
sults are shown as mean±SD. Experiment was performed in triplicate. (B) Hsp70 mRNA levels determined by RT-PCR; results are shown as 
mean±SD. Experiment was performed in two sets of triplicate. (C) Detection of the Hsp70 protein in keloid fibroblasts by western blot analysis 24 h 
and 48 h after transfection (*p<0.05). Each experiment was performed in triplicate; representative data are shown here. Hsp70, heat shock protein 70; 
siRNA, small interfering RNA; MTT, tetrazolium-based colorimetric assay; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; RT-PCR, real-time 
polymerase chain reaction.
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cells transfected with a scrambled siRNA, the collagen-I and 
collagen-III mRNA levels were reduced by 76% and 71%, re-
spectively, 24 h after transfection (p<0.05) and by an addition-
al 79% and 81%, respectively, 48 h after transfection (p<0.05) 
(Fig. 3A). The collagens secretion was suppressed in the cul-
tures transfected with Hsp70 siRNA-1, relative to the control 
cultures, 48 h after transfection (p<0.05), but not 24 h after 
transfection (Fig. 3B). 
Hsp70 siRNA transfection altered MMPs and 
TIMPs expression 
The Hsp70 siRNA transfection significantly reduced MMP-14, 
TIMP-1, and TIMP-2 mRNA levels; however, the MMP-2 mRNA 
levels increased after the transfection (Fig. 4A). The western 
blot revealed decreased levels of MMP-14, TIMP-1, and TIMP-
2 proteins after transfection (Fig. 4B). 
DISCUSSION
In the present study, we found that transfection of keloid fibro-
blasts with Hsp70 siRNA knocked down Hsp70 expression, re-
sulting in reduced expression of collagen-I, collagen-III, MMP-
14, TIMP-1, and TIMP-2, and that the siRNA-mediated Hsp70 
knockdowns did not affect the viability of the keloid fibroblasts, 
suggesting a possible role for Hsp70 in keloid development. 
Heat shock proteins are stress-response proteins that are 
expressed under a variety of stimuli and are binding polypep-
tides to facilitate the correct folding, transport, and localiza-
tion of the mature proteins.12 They also associate with dena-
tured or partially unfolded proteins, helping the distressed 
proteins to refold. Among the many heat shock proteins, the 
members of the Hsp70 family are the most prominent and 
best characterized, and are well known to have cytoprotec-
tive,13-15 anti-inflammatory,16 and molecular chaperone activi-
ties.10 Previously, increased expression of Hsp70 in keloid tis-
sues has been reported in other studies. Totan, et al.8 showed 
overexpression of Hsp27, Hsp47, and Hsp70 in keloid tissues, 
and Javad and Day9 showed up-regulated Hsp60 and Hsp70 
in keloid tissue using a protein profiling. In support of these 
reports, we previously showed that Hsp70 is also increased in 
cultured fibroblasts.7 However, the functional role of Hsp70 in 
collagen has not yet been investigated.
The overproduction of extracellular matrix proteins and es-
pecially that of collagen is a prominent phenomenon in ke-
loids. Previous studies suggest that the ratio of collagen-I to 
collagen-III is altered in keloids.17,18 The levels of collagen-I 
generally increase in keloid fibroblasts;18,19 whereas the levels 
of collagen-III vary: Peltonen, et al.20 and Ala-Kokko, et al.19 
found unaltered collagen-III mRNA levels in keloids, while 
Syed, et al.21 and Naitoh, et al.17 found increased collagen-III 
mRNA and protein levels in keloids. Those authors suggested 
Fig. 4. Matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) 24 h and 48 h after transfection. (A) Expression of MMP 
and TIMP mRNAs after Hsp70 siRNA transfection: MMP-14, TIMP-1, and TIMP-2 mRNAs were significantly suppressed; however, MMP-2 was not; 
results are shown as mean±SD. Each experiment was performed in two sets of triplicate. (B) Western-blot analysis of MMP-2, MMP-14, TIMP-1, and 
TIMP-2 protein levels (*p<0.05). Each experiment was performed in triplicate. Hsp70, heat shock protein 70; siRNA, small interfering RNA; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase.
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that the variation in collagen-III mRNA levels among different 
studies may be explained by the heterogeneity within the ke-
loid lesion itself.
In our study, we focused on the mechanism of excessive col-
lagen deposition that leads to keloid formation. Previously, we 
reported that the level of Hsp70 protein is increased in keloid 
fibroblasts compared with that in normal fibroblasts,7 leading 
us to examine the role of Hsp70 in keloid pathogenesis in the 
present study, especially the excessive deposition of collagen, 
by suppressing Hsp70 expression in keloid fibroblasts.
We used siRNAs to suppress Hsp70 expression. As shown in 
previous studies,22 RNA interference using siRNA is a useful 
biological strategy to study keloid pathogenesis. Therefore, we 
designed two siRNAs and transfected them into keloid fibro-
blasts, thereby successfully suppressing the expression of 
Hsp70. Of the two siRNAs, Hsp70 siRNA-1 more constantly 
suppressed the expression of Hsp70 in repeated experiments. 
Therefore, we decided to further evaluate Hsp70 knockdown 
using only siRNA-1. After successfully down-regulating Hsp70 
expression, we detected the collagen production to reflect the 
condition of collagen accumulation in keloids. We found that 
the mRNA levels of collagen-I and collagen-III decreased sig-
nificantly, corresponding to the down-regulation of Hsp70. 
We also found that the amount of extracellular collagen in the 
culture media was significantly decreased. Taken together, 
our results suggest that the suppression of Hsp70 by siRNAs 
could inhibit the synthesis and secretion of collagen, sup-
pressing excessive collagen accumulation found in keloids.
When Hsp70 is overexpressed in animal models by genetic 
or pharmacologic induction, it is protective of various diseases, 
such as gastric and small-intestinal lesions, inflammatory bow-
el diseases, ultraviolet-induced skin damage, and Alzheimer’s 
disease.23-29 Recently, Tanaka, et al.30 and Namba, et al.31 dem-
onstrated that Hsp70 has a protective role in pulmonary fibro-
sis in a genetically altered mouse model. In contrast to previ-
ous studies, our data showed increased expression of Hsp70 in 
keloids and the possible regulatory role in collagen synthesis. 
The contrasting results could be due to differences in the cell 
types: human lung adenocarcinoma cell lines (A539, H1975, 
and PC9)30 and genetically altered mouse cells31 versus hu-
man keloid fibroblasts. The overexpression of Hsp70 in epi-
thelial cells may play a protective role via cytoprotective and 
anti-inflammatory effects; however, the overexpression of 
Hsp70 in altered fibroblasts, such as keloid fibroblasts, may 
lead to the pathogenic maintenance of excessive extracellular 
matrix-protein production.
Another heat shock protein, Hsp47 is a collagen-specific 
molecular chaperone that plays a critical role in normal pro-
collagen biosynthesis in mammals. Chen, et al.6,32 demonstrat-
ed that the overexpression of Hsp47 in keloid fibroblasts may 
induce excessive collagen accumulation by enhancing the 
synthesis and secretion of collagen. Their results are in good 
agreement with our present results: overexpressed heat shock 
proteins in keloid fibroblasts might cause excessive collagen 
accumulation, leading to keloid formation.
Collagenases such as MMPs and TIMPs are involved in cre-
ating an imbalance between the production and the degrada-
tion of collagen in keloids. Several MMPs have been shown to 
mediate the breakdown of collagen-I and III.33 MMP-2 and 
MMP-9 activities persist after wound closure and seem to play 
a critical role in the remodeling phase.34 Keloids were previ-
ously found to contain high levels of MMP-2 and low or normal 
levels of MMP-9.35,36 MMP-2, secreted as latent pro-MMP-2, 
requires activation in the presence of TIMP-2 and surface 
MMP-14 binding.37 This TIMP-2:MMP-14 complex acts as a re-
ceptor for pro-MMP-2 at the cell surface and converts pro-
MMP-2 to active MMP-2.38 Previous studies indicate that the 
activation of MMP-2 via the increased expression of MMP-14 
and TIMP-2 is related to tumor progression and invasion.39-45 
It has also been demonstrated that increased MMP-2 activity 
in keloids coupled with TIMP-2 and MMP-14 expression by 
keloid fibroblasts can contribute to the invasion of surround-
ing tissues by keloid fibroblasts.36 We found that the down-
regulation of Hsp70 increased levels of MMP-2 mRNAs and de-
creased levels of TIMP-1, TIMP-2, and MMP-14 mRNAs and 
proteins. Although the MMP-2 mRNA levels increased, the 
decreased levels of MMP-14 and TIMP-2 will likely suppress 
the conversion of pro-MMP-2 to active MMP-2, thereby re-
ducing the ECM degradation and invasion of the keloid fibro-
blasts into peripheral normal region.
In summary our results, together with our previous results, 
support the hypothesis that the overexpression of Hsp70 in 
keloid fibroblasts might play a regulatory role in the excessive 
collagen production and secretion in keloids. Hence, the down-
regulation of Hsp70 could be a therapeutic option for keloids, 
suppressing collagen deposition and preventing keloid pro-
gression. 
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